Click a link below to view the mailing archive as if it had been sent to you.
| 2026-02-28 00:15 | | Biopharma in depth — February 27, 2026 |
| 2026-02-27 12:15 | | Eli Lilly's powerful supercomputer goes live in AI push and more... |
| 2026-02-27 00:15 | | Boehringer's Hernexeos secures speedy first-line expansion in FDA's 2nd national priority nod and more... |
| 2026-02-26 12:15 | | Bristol Myers' $800M ADC hits primary survival endpoints in phase 3 breast cancer trial and more... |
| 2026-02-26 00:15 | | Sarepta CEO Doug Ingram To Step Down as Muscular Dystrophy Mission Hits Home and more... |
| 2026-02-25 12:15 | | GSK to acquire 35Pharma in $950M deal for cardiovascular drug and more... |
| 2026-02-25 00:15 | | Werewolf weighs sale or merger as cash reserves whimper and more... |
| 2026-02-24 12:15 | | Novo, searching for a spark, spotlights new data for three-pronged obesity drug and more... |
| 2026-02-24 00:15 | | Pfizer in diabetes drug deal with Sciwind Biosciences and more... |
| 2026-02-23 12:15 | | Novo's CagriSema loses phase 3 battle with Lilly's Zepbound, knocking 15% off share price and more... |
| 2026-02-20 12:15 | | Biohaven charts comeback path after FDA blow, placing bets on obesity and more... |
| 2026-02-19 12:15 | | FDA untitled letter lambastes efficacy claims in ad for J&J’s Tremfya and more... |
| 2026-02-19 00:15 | | Can Trump win over critics with MFN drug pricing plan? Former Biden advisor weighs in and more... |
| 2026-02-18 12:15 | | FDA reverses course on Moderna’s mRNA flu shot application, promising August decision and more... |
| 2026-02-18 00:15 | | Roche adds to Gazyva's growing autoimmune pedigree with new phase 3 kidney condition victory and more... |
| 2026-02-17 12:15 | | Lilly targets India as global export hub amid booming Mounjaro sales, executive says and more... |
| 2026-02-13 12:15 | | All eyes on Vertex’s kidney franchise, as painkiller Journavx tops half a million scripts and more... |
| 2026-02-12 12:15 | | Sanofi ousts Paul Hudson after 'bumpy ride,' enlists Merck KGaA CEO to lead the French pharma and more... |
| 2026-02-12 00:15 | | GSK, Teva quietly settle Coreg 'skinny label' dispute after long legal back-and-forth and more... |
| 2026-02-11 12:15 | | Gilead dips as ‘strong’ earnings outweighed by high expectations for new HIV drug and more... |
| 2026-02-10 12:15 | | AstraZeneca sets sights on 25+ blockbusters by 2030 to fuel $80B revenue ambition and more... |
| 2026-02-10 00:15 | | FDA says Novo Nordisk’s TV ad for obesity pill includes ‘false or misleading’ claims and more... |
| 2026-02-09 12:15 | | Lilly buys Orna in $2.4B deal to enter in vivo CAR-T arena and more... |
| 2026-02-06 12:15 | | Biogen shares rise as Q4 earnings beat expectations, 2026 profit outlook strong and more... |
| 2026-02-06 00:15 | | Makary promises 'swift action' against compounders and more... |
| 2026-02-05 12:15 | | Novo Nordisk says it will take legal action after Hims & Hers reveals $49 copy of Wegovy pill and more... |
| 2026-02-04 12:15 | | Novo Nordisk shares tumble 18% as CEO warns it will get worse before it gets better and more... |
| 2026-02-03 12:15 | | Pfizer's $10B monthly GLP-1 bet generates competitive weight loss in phase 2b and more... |
| 2026-02-03 00:15 | | Novo combination obesity shot meets goal in diabetes trial and more... |
| 2026-02-02 12:15 | | Obesity market sales potential tightens as Novo and Lilly enter new era and more... |
| 2026-02-02 00:15 | | Lilly rounds out quartet of new US plants with $3.5B injectable and device facility in PA and more... |
